These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9291 related articles for article (PubMed ID: 10721488)

  • 1. Melanoma cell autonomous growth: the Rb/E2F pathway.
    Halaban R
    Cancer Metastasis Rev; 1999; 18(3):333-43. PubMed ID: 10721488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
    Bandyopadhyay D; Medrano EE
    Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
    Woo MS; Sánchez I; Dynlacht BD
    Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
    von Willebrand M; Zacksenhaus E; Cheng E; Glazer P; Halaban R
    Cancer Res; 2003 Mar; 63(6):1420-9. PubMed ID: 12649208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
    Watanabe G; Albanese C; Lee RJ; Reutens A; Vairo G; Henglein B; Pestell RG
    Mol Cell Biol; 1998 Jun; 18(6):3212-22. PubMed ID: 9584162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
    Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
    Park DS; Morris EJ; Bremner R; Keramaris E; Padmanabhan J; Rosenbaum M; Shelanski ML; Geller HM; Greene LA
    J Neurosci; 2000 May; 20(9):3104-14. PubMed ID: 10777774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
    Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
    Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
    Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
    Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
    Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of retinoblastoma protein-independent hematopoietic cell cycle by the pRB-related p130.
    Hoshikawa Y; Mori A; Amimoto K; Iwabe K; Hatakeyama M
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8574-9. PubMed ID: 9671719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an E2F-p130 complex formed during growth arrest.
    Corbeil HB; Branton PE
    Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 465.